NNC0662-0419 for Obesity Treatment
A Research Study Comparing Different Ways of Increasing the Dose of NNC0662-0419 in Participants With Obesity
Recruiting
Phase 2
Interventional Study
Obesity
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Trial phase
- Phase 2
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 230 (estimated)
- Sponsor
- Novo Nordisk A/S · Industry
Who this trial is looking for
This trial is looking for adults with obesity who want to lose weight. Participants will take a treatment called NNC0662-0419 to see if it helps them safely lose weight.
Are You a Good Fit for This Trial?
You may be able to join if
- I am 18 years or older
- I have a body mass index (BMI) of 30 or more
- I want to lose at least 25% of my body weight
You may not be able to join if
- I am allergic to the treatment or similar products
- I have taken any weight loss medications in the last 90 days
- My glycated hemoglobin (HbA1c) is 6.5% or higher
- I have a history of type 1 or type 2 diabetes
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The purpose of the study is to find out if NNC0662-0419 is safe and effective for treating participants living with obesity.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Male or female (sex assigned at birth, inclusive of all gender identities).
* Age 18 years or above at the time of signing the informed consent.
* Body mass index (BMI) greater than or equal to (≥) 30.0 kilogram per square meter (kg/m\^2) at screening.
* Participant must have …
Contacts